Contact
About Nucletron
About Nucletron
Company History
Nucletron Worldwide
Careers
Management Board
Resource Library
About Brachytherapy
Patient information
Products & Solutions
Type of cancer
Head & Neck
Skin & Surface
Bronchus & Esophagus
Prostate
Rectum & Bladder
Breast
Pancreas & Bile Duct
Gynecology
Type of product
Imaging
Treatment Planning
Treatment Delivery
Applicators
Service & Support
Service and Support
oncoSupport Discover
What's new and what's next in radiation oncology
oncoSupport Define
Complete planning and project management
oncoSupport Deliver
Maintain and enhance your radiation oncology solutions
oncoSupport Develop
New services and new solutions
Training & Education
Training and Education
An overview of all training and education opportunities at Nucletron
Choose Category
Application Courses
Technical Courses
Clinical Workshop
My Nucletron
Login
Login to My Nucletron
Register
Register a new account
Forgot password?
Request a new password
Home
News & Events
New PLATO Brachytherapy – Seeds Module builds on more than 20 Years of Nucletron Experience in Permanent Seed Implantation Planning
May 7 1999
Veenendaal, 7 May, 1999
– Nucletron, the world leader in brachytherapy, is proud to announce the immediate release of PLATO Brachytherapy - Seeds treatment planning software. The clinical functionality of this comprehensive software package for prostate treatment planning using low dose permanent seeds is directly based on Nucletron’s highly acclaimed planning module NPS-MLDR/Seed. With its clinically based user interface, the module is designed to streamline the treatment planning process.
Nucletron has over 20 years of experience in permanent seed implantation treatment planning. The new release of the PLATO– Brachytherapy-Seeds software builds on the NPS software, which originated in 1982. As a result of working closely with leading centers in the USA, the UK and the Netherlands, the new version has several unique features but remains easy to use, containing tools that make it friendly for the physicist and the physician.
A major advantage of the PLATO treatment planning system, which benefits the whole radiotherapy team, is its modularity. The unique user interface that is common to all PLATO modules means that screens across the range look and feel the same. Thus training time for additional modules are minimal and the learning curve steep; important considerations in terms of patient throughput and costs. As Rob van der Laarse PhD, Nucletron’s Scientific Advisor, explains, "Our brachytherapy planning modules provide all the "tools" for simple to complex treatment planning." But modularity isn’t the whole story, with the PLATO treatment planning system our users can be confident that Nucletron’s dedicated brachytherapy research and development team and clinical support staff are there to support them.
Nucletron, specializes in some of the most innovative products used in cancer treatment. The company has 11 sales, service and clinical support offices world-wide, including its corporate headquarters in The Netherlands. The American office, Nucletron Corp., is located in Columbia, MD, to serve the United States, Mexico and Canada.
For further information please visit our web site www.nucletron.com or contact our Customer Support Department, e-mail
info@nucletron.com
.